2014 Q2 Form 10-Q Financial Statement

#000158080814000006 Filed on August 04, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $45.13M $30.13M
YoY Change 49.79% 7.3%
Cost Of Revenue $10.34M $6.914M
YoY Change 49.55% 11.88%
Gross Profit $34.79M $23.22M
YoY Change 49.86% 6.01%
Gross Profit Margin 77.09% 77.05%
Selling, General & Admin $29.51M $19.42M
YoY Change 51.94% 21.83%
% of Gross Profit 84.81% 83.65%
Research & Development $11.87M $8.336M
YoY Change 42.38% 33.38%
% of Gross Profit 34.11% 35.9%
Depreciation & Amortization $2.500M $1.700M
YoY Change 47.06%
% of Gross Profit 7.19% 7.32%
Operating Expenses $35.52M $32.56M
YoY Change 9.09% 46.71%
Operating Profit -$724.0K -$9.339M
YoY Change -92.25% 3120.34%
Interest Expense $125.0K $33.00K
YoY Change 278.79% -52.86%
% of Operating Profit
Other Income/Expense, Net -$263.0K -$716.0K
YoY Change -63.27%
Pretax Income -$987.0K -$10.06M
YoY Change -90.18% 47.22%
Income Tax $309.0K $158.0K
% Of Pretax Income
Net Earnings -$1.296M -$10.21M
YoY Change -87.31% 45.9%
Net Earnings / Revenue -2.87% -33.9%
Basic Earnings Per Share -$0.02 -$1.12
Diluted Earnings Per Share -$0.02 -$1.12
COMMON SHARES
Basic Shares Outstanding 59.71M shares 9.144M shares
Diluted Shares Outstanding 59.71M shares 9.144M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $112.1M
YoY Change
Cash & Equivalents $112.1M $58.37M
Short-Term Investments
Other Short-Term Assets $4.400M
YoY Change
Inventory $18.54M
Prepaid Expenses
Receivables $40.46M
Other Receivables $0.00
Total Short-Term Assets $175.5M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $11.95M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.784M
YoY Change
Total Long-Term Assets $16.73M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $175.5M
Total Long-Term Assets $16.73M
Total Assets $192.2M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.81M
YoY Change
Accrued Expenses $19.65M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $63.13M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $2.162M
YoY Change
Total Long-Term Liabilities $2.162M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $63.13M
Total Long-Term Liabilities $2.162M
Total Liabilities $79.82M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$153.5M
YoY Change
Common Stock $1.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $112.4M
YoY Change
Total Liabilities & Shareholders Equity $192.2M
YoY Change

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$1.296M -$10.21M
YoY Change -87.31% 45.9%
Depreciation, Depletion And Amortization $2.500M $1.700M
YoY Change 47.06%
Cash From Operating Activities -$6.750M -$5.930M
YoY Change 13.83%
INVESTING ACTIVITIES
Capital Expenditures -$1.770M -$1.190M
YoY Change 48.74%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.770M -$1.190M
YoY Change 48.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.530M 49.39M
YoY Change -103.1%
NET CHANGE
Cash From Operating Activities -6.750M -5.930M
Cash From Investing Activities -1.770M -1.190M
Cash From Financing Activities -1.530M 49.39M
Net Change In Cash -10.05M 42.27M
YoY Change -123.78%
FREE CASH FLOW
Cash From Operating Activities -$6.750M -$5.930M
Capital Expenditures -$1.770M -$1.190M
Free Cash Flow -$4.980M -$4.740M
YoY Change 5.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10805000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9228000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37704000 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40455000 USD
CY2014Q2 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
100000 USD
CY2013Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
100000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15514000 USD
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19645000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16091000 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20539000 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
265836000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12185000 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2738000 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2462000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10276000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
38772000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39009000 shares
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10305000 shares
us-gaap Cost Of Goods Sold
CostOfGoodsSold
9800000 USD
CY2014Q2 us-gaap Assets
Assets
192196000 USD
CY2013Q4 us-gaap Assets
Assets
93794000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
175467000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
78719000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
655000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
195000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20793000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112101000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58372000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23867000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
34505000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
91308000 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
65600000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10032000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59768000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10032000 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59768000 shares
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
1000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents and accounts receivable. Our cash and cash equivalents are invested in high-credit quality financial instruments with banks and financial institutions. Management believes that the financial institutions that hold our cash and cash equivalents are financially sound and, accordingly, are subject to minimal credit risk. Such deposits may be in excess of insured limits provided on such deposits.</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accounts receivable are unsecured and represent amounts due to us based on contractual obligations of our customers. We mitigate credit risk in respect to accounts receivable by performing periodic credit evaluations of our customers to assess the probability of accounts receivable collection based on a number of factors, including past transaction experience with the customer, evaluation of their credit history, limiting the credit extended and review of the invoicing terms of the contract. We generally do not require our customers to provide collateral to support accounts receivable. We have recorded an allowance for doubtful accounts for those receivables that we have determined not to be collectible.</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant customers, including distribution channel partners and direct customers, are those which represent more than 10% of our total revenues for each period presented, or our gross accounts receivable balance as of each respective balance sheet date. </font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues from our significant customers as a percentage of our total revenues for the three and six months ended June 30, 2014 and 2013 are follows:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended&#160;<br clear="none"/>&#160;June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended&#160;<br clear="none"/>&#160;June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Customers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer B</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer C</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:13.658536585365855%;border-collapse:collapse;text-align:left;"><tr><td colspan="1" rowspan="1"></td></tr><tr><td width="100%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">* represents less than 10% of total revenues</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> As of June 30, 2014, another customer represented </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> of our total gross accounts receivable. No other customers accounted for 10% or more our total accounts receivable for the periods presented.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2014Q1 us-gaap Contractual Obligation
ContractualObligation
12000000 USD
CY2014Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
39997114 shares
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20393000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13518000 USD
CY2014Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10340000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6914000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4894000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4700000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
14837000 USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7410000 USD
us-gaap Cost Of Services
CostOfServices
5556000 USD
us-gaap Cost Of Services
CostOfServices
3718000 USD
CY2013Q2 us-gaap Cost Of Services
CostOfServices
2020000 USD
CY2014Q2 us-gaap Cost Of Services
CostOfServices
2930000 USD
CY2014Q2 us-gaap Deferred Revenue
DeferredRevenue
45842000 USD
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
41232000 USD
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
31315000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
28448000 USD
CY2014Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
14527000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
12784000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4738000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3151000 USD
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2500000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3100000 USD
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1700000 USD
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5531000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3697000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7527000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10894000 USD
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.12
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.07
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.12
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9015000 USD
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11745000 USD
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
17500000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M26D
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
226000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
43000 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
6993000 USD
CY2014Q2 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
6993000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-106000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-15000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
23217000 USD
us-gaap Gross Profit
GrossProfit
46194000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
34792000 USD
us-gaap Gross Profit
GrossProfit
70484000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10055000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-987000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-18367000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5884000 USD
CY2013Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
10407000 USD
CY2014Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1368000 USD
CY2013Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
4800000 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7999000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
18541000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
17166000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10625000 USD
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
10542000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
379000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
514000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
309000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2105000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1533000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2644000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-320000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3632000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1263000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2862000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4610000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4265000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2797000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1445000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-6119000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-124000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
29000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3070000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-618000 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
125000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
33000 USD
us-gaap Interest Expense
InterestExpense
712000 USD
us-gaap Interest Expense
InterestExpense
46000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6541000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
102499000 USD
CY2014Q2 us-gaap Liabilities
Liabilities
79822000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93794000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
192196000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
63597000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
63133000 USD
CY2013Q4 us-gaap Line Of Credit
LineOfCredit
20000000 USD
CY2014Q2 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4343000 USD
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4666000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4784000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5274000 USD
CY2014Q2 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-5859000 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-4013000 USD
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
8204000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
104817000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50434000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1903000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3791000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9718000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14026000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-10213000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-1296000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18746000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6398000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10246000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1296000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7548000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18779000 USD
CY2014Q2 us-gaap Noncurrent Assets
NoncurrentAssets
13011000 USD
CY2013Q4 us-gaap Noncurrent Assets
NoncurrentAssets
10862000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1410000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-716000 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-263000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-875000 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
35516000 USD
us-gaap Operating Expenses
OperatingExpenses
75493000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
32556000 USD
us-gaap Operating Expenses
OperatingExpenses
63151000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-724000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9339000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-16957000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5009000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6118000 USD
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2162000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1903000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3791000 USD
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
33000 USD
us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
1150000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3056000 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4370000 USD
CY2014Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
192700000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
49479000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-148000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-153000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
813000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25892000 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32484000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9801000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11945000 USD
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
2891000 USD
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
2592000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
458000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
59000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
20000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
539000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23074000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8336000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16108000 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11869000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-147065000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-153463000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2600000 USD
CY2014Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
600000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1100000 USD
CY2013Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
1600000 USD
us-gaap Revenues
Revenues
90877000 USD
CY2013Q2 us-gaap Revenues
Revenues
30131000 USD
CY2014Q2 us-gaap Revenues
Revenues
45132000 USD
us-gaap Revenues
Revenues
59712000 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
34122000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
23064000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
46333000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
70539000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
59712000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
90877000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
45132000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
30131000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
13379000 USD
CY2014Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
11010000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
20338000 USD
CY2013Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
7067000 USD
aten Costs Related To Initial Public Offering Included In Accounts Payable And Accrued Liabilities
CostsRelatedToInitialPublicOfferingIncludedInAccountsPayableAndAccruedLiabilities
0 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
4697000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
49664000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.59
CY2014Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23975000 USD
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15723000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31312000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
45538000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4776000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1727000 USD
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
864000 USD
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3006000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1111000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8818000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
444000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1264000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.96
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
77371000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
58515000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9971000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9741000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.14
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.44
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.73
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
75244000 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9284000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.27
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.54
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.71
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.36
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y8M12D
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
7536000 USD
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
3300000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1050000 shares
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-134880000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
112374000 USD
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2156000 USD
CY2014Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
3234000 USD
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
-33000 USD
CY2013Q2 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
-33000 USD
CY2014Q2 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
0 USD
us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
-1150000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1800000 USD
CY2014Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2300000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Those estimates and assumptions affect revenue recognition and deferred revenue, allowance for doubtful accounts, valuation of inventory, contingencies and litigation, and determination of fair value of stock-based compensation. These estimates are based on information available as of the date of the condensed consolidated financial statements; therefore, actual results could differ from management&#8217;s estimates.</font></div></div>
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59711000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9075000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36712000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9144000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9075000 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
59711000 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9144000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36712000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36712000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9144000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59711000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9075000 shares
us-gaap Year Founded
YearFounded
2004
aten Costs Related To Initial Public Offering Included In Accounts Payable And Accrued Liabilities
CostsRelatedToInitialPublicOfferingIncludedInAccountsPayableAndAccruedLiabilities
1424000 USD
aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-1364000 USD
CY2014Q2 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-138000 USD
CY2013Q2 aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-683000 USD
aten Interest Income And Other Income Expense Net
InterestIncomeAndOtherIncomeExpenseNet
-163000 USD
CY2014Q2 aten Net Proceeds From Issuance Of Initial Public Offering After Deducting Underwriting Discounts And Commissions And Offering Costs
NetProceedsFromIssuanceOfInitialPublicOfferingAfterDeductingUnderwritingDiscountsAndCommissionsAndOfferingCosts
120200000 USD
CY2014Q2 aten Payments Related To Settlement
PaymentsRelatedToSettlement
5000000 USD
aten Proceeds From Exercise Of Common Stock Options Net Of Repurchases Of Common Stock
ProceedsFromExerciseOfCommonStockOptionsNetOfRepurchasesOfCommonStock
-2658000 USD
aten Proceeds From Exercise Of Common Stock Options Net Of Repurchases Of Common Stock
ProceedsFromExerciseOfCommonStockOptionsNetOfRepurchasesOfCommonStock
-829000 USD
aten Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
0 USD
aten Proceeds From Issuance Initial Public Offering Net
ProceedsFromIssuanceInitialPublicOfferingNet
122312000 USD
aten Reclassification Of The Convertible Preferred Stock Warrant Liability To Additional Paid In Capital Upon The Exercise Of The Convertible Preferred Stock Warrants
ReclassificationOfTheConvertiblePreferredStockWarrantLiabilityToAdditionalPaidInCapitalUponTheExerciseOfTheConvertiblePreferredStockWarrants
0 USD
aten Reclassification Of The Convertible Preferred Stock Warrant Liability To Additional Paid In Capital Upon The Exercise Of The Convertible Preferred Stock Warrants
ReclassificationOfTheConvertiblePreferredStockWarrantLiabilityToAdditionalPaidInCapitalUponTheExerciseOfTheConvertiblePreferredStockWarrants
2199000 USD
aten Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
243000 USD
aten Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
286000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001580808
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59813356 shares
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
dei Entity Registrant Name
EntityRegistrantName
A10 Networks, Inc.
dei Trading Symbol
TradingSymbol
ATEN

Files In Submission

Name View Source Status
0001580808-14-000006-index-headers.html Edgar Link pending
0001580808-14-000006-index.html Edgar Link pending
0001580808-14-000006.txt Edgar Link pending
0001580808-14-000006-xbrl.zip Edgar Link pending
aten-20140630.xml Edgar Link completed
aten-20140630.xsd Edgar Link pending
aten-20140630_cal.xml Edgar Link unprocessable
aten-20140630_def.xml Edgar Link unprocessable
aten-20140630_lab.xml Edgar Link unprocessable
aten-20140630_pre.xml Edgar Link unprocessable
aten-2014630x10q.htm Edgar Link pending
exhibit10120140630.htm Edgar Link pending
exhibit10220140630.htm Edgar Link pending
exhibit10320140630.htm Edgar Link pending
exhibit10420140630.htm Edgar Link pending
exhibit10520140630.htm Edgar Link pending
exhibit31120140630.htm Edgar Link pending
exhibit31220140630.htm Edgar Link pending
exhibit32120140630.htm Edgar Link pending
exhibit32220140630.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
netherlands.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending